Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E L Saenko

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
The Journal of Biological Chemistry|December 23, 1999
Role of the low density lipoprotein-related protein receptor in mediation of factor VIII catabolismE L Saenko, A V Yakhyaev, I Mikhailenko, et al.
Blood|February 7, 2001
Hemophilia A mutations associated with 1-stage/2-stage activity discrepancy disrupt protein-protein interactions within the triplicated A domains of thrombin-activated factor VIIIaS W Pipe, E L Saenko, A N Eickhorst, et al.
Journal of Thrombosis and Haemostasis : JTH|January 27, 2005
Initiation and propagation of coagulation from tissue factor-bearing cell monolayers to plasma: initiator cells do not regulate spatial growth rateM V Ovanesov, N M Ananyeva, M A Panteleev, et al.
Journal of Thrombosis and Haemostasis : JTH|October 26, 2005
Two subpopulations of thrombin-activated platelets differ in their binding of the components of the intrinsic factor X-activating complexM A Panteleev, N M Ananyeva, N J Greco, et al.
Journal of Thrombosis and Haemostasis : JTH|July 23, 2003
The future of recombinant coagulation factorsE L Saenko, N M Ananyeva, M Shima, et al.
Blood|December 24, 1998
Mild hemophilia A caused by increased rate of factor VIII A2 subunit dissociation: evidence for nonproteolytic inactivation of factor VIIIa in vivoS W Pipe, A N Eickhorst, S H McKinley, et al.
British Journal of Haematology|February 23, 1999
Human factor VIII can be packaged and functionally expressed in an adeno-associated virus background: applicability to haemophilia A gene therapyD V Gnatenko, E L Saenko, J Jesty, et al.
Journal of Thrombosis and Haemostasis : JTH|May 19, 2006
Factor V C2 domain contains a major thrombin-binding site responsible for thrombin-catalyzed factor V activationH Suzuki, M Shima, K Nogami, et al.
Thrombosis Research|April 12, 2001
In hemophilia A and autoantibody inhibitor patients: the factor VIII A2 domain and light chain are most immunogenicD H Scandella, H Nakai, M Felch, et al.
Blood|September 18, 1997
Loss of tolerance to exogenous and endogenous factor VIII in a mild hemophilia A patient with an Arg593 to Cys mutationA R Thompson, M E Murphy, M Liu, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
The Journal of Biological Chemistry|December 23, 1999
Role of the low density lipoprotein-related protein receptor in mediation of factor VIII catabolismE L Saenko, A V Yakhyaev, I Mikhailenko, et al.
Blood|February 7, 2001
Hemophilia A mutations associated with 1-stage/2-stage activity discrepancy disrupt protein-protein interactions within the triplicated A domains of thrombin-activated factor VIIIaS W Pipe, E L Saenko, A N Eickhorst, et al.
Journal of Thrombosis and Haemostasis : JTH|January 27, 2005
Initiation and propagation of coagulation from tissue factor-bearing cell monolayers to plasma: initiator cells do not regulate spatial growth rateM V Ovanesov, N M Ananyeva, M A Panteleev, et al.
Journal of Thrombosis and Haemostasis : JTH|October 26, 2005
Two subpopulations of thrombin-activated platelets differ in their binding of the components of the intrinsic factor X-activating complexM A Panteleev, N M Ananyeva, N J Greco, et al.
Journal of Thrombosis and Haemostasis : JTH|July 23, 2003
The future of recombinant coagulation factorsE L Saenko, N M Ananyeva, M Shima, et al.
Blood|December 24, 1998
Mild hemophilia A caused by increased rate of factor VIII A2 subunit dissociation: evidence for nonproteolytic inactivation of factor VIIIa in vivoS W Pipe, A N Eickhorst, S H McKinley, et al.
British Journal of Haematology|February 23, 1999
Human factor VIII can be packaged and functionally expressed in an adeno-associated virus background: applicability to haemophilia A gene therapyD V Gnatenko, E L Saenko, J Jesty, et al.
Journal of Thrombosis and Haemostasis : JTH|May 19, 2006
Factor V C2 domain contains a major thrombin-binding site responsible for thrombin-catalyzed factor V activationH Suzuki, M Shima, K Nogami, et al.
Thrombosis Research|April 12, 2001
In hemophilia A and autoantibody inhibitor patients: the factor VIII A2 domain and light chain are most immunogenicD H Scandella, H Nakai, M Felch, et al.
Blood|September 18, 1997
Loss of tolerance to exogenous and endogenous factor VIII in a mild hemophilia A patient with an Arg593 to Cys mutationA R Thompson, M E Murphy, M Liu, et al.
Pageof 6